Boyce & Associates Wealth Consulting’s AbbVie ABBV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$301K	Buy	1,385 +153	+12%	+$33.9K	0.23%	62
2025 Q4	$282K	Sell	1,232 -42	-3%	-$9.57K	0.24%	59
2025 Q3	$295K	Buy	1,274 +10	+0.8%	+$2.04K	0.24%	56
2025 Q2	$235K	Buy	1,264 +11	+0.9%	+$2.04K	0.21%	66
2025 Q1	$263K	Buy	1,253 +1	+0.1%	+$194	0.26%	57
2024 Q4	$222K	Buy	1,252 +1	+0.1%	+$184	0.23%	66
2024 Q3	$247K	Buy	1,251 +2	+0.2%	+$373	0.26%	64
2024 Q2	$214K	Buy	1,249 +1	+0.1%	+$166	0.25%	64
2024 Q1	$227K	Buy	+1,248	New	+$215K	0.29%	53
2023 Q2	–	Sell	-1,274	Closed	-$206K	–	49
2023 Q1	$206K	Buy	1,274 +34	+3%	+$5.2K	0.37%	47
2022 Q4	$200K	Buy	+1,240	New	+$190K	0.38%	44
2022 Q2	–	Sell	-1,236	Closed	-$200K	–	48
2022 Q1	$200K	Buy	+1,236	New	+$180K	0.3%	51